URI Description
sg:pub.10.1038/news.2008.410 Is a universal flu vaccine on its way?
sg:pub.10.1186/1756-0500-3-92 A universal long-term flu vaccine may not prevent severe epidemics
sg:pub.10.1038/d41586-019-02751-w Towards a universal flu vaccine
sg:pub.10.1038/d41586-021-02810-1 Daily briefing: mRNA vaccines take on flu
sg:pub.10.2165/00128415-200912760-00010 MHRA announce safety monitoring programme for swine flu vaccines
sg:pub.10.1038/nm0113-4 Cell-based vaccines yield only modest advances for seasonal flu
sg:pub.10.1038/nbt1109-971 Steve Reed
sg:pub.10.1007/s40278-020-77372-4 Severe headache or anaesthesia/paraesthesia with seasonal flu vaccines
sg:pub.10.1038/nature.2014.14940 Mutations explain poor showing of 2012 flu vaccine
sg:pub.10.1038/d41573-021-00176-7 mRNA flu shots move into trials
sg:pub.10.1038/438023a Race is on for flu vaccine
sg:pub.10.1038/nm0412-471 Four-strain flu vaccines coming to a pharmacy near you
sg:pub.10.1038/d41586-019-01524-9 Long-term studies will track indelible marks of first flu
sg:pub.10.1007/s40278-021-05471-5 Concomitant administration of COVD-19 vaccines with 'flu vaccines: acceptable reactogenicity profiles
sg:pub.10.1038/nbt1205-1457 Cautious industry welcome for US flu vaccine plan
sg:pub.10.1007/bf03289193 GIVE UP THE BATTLE WITH FLU VACCINES?
sg:pub.10.2165/00151234-200404500-00023 Pharmacist provision of vaccines linked to higher 'flu vaccine coverage
sg:pub.10.1007/bf03280638 Canadian government and Shire agree on 'flu vaccines
sg:pub.10.1007/bf03300336 THREE NEW FLU VACCINES TO CHOOSE FROM THIS WINTER
sg:pub.10.1038/d41586-019-02756-5 Accelerating flu protection
sg:pub.10.2165/00128413-199811610-00014 New flu and pneumococcal vaccines coming soon?
sg:pub.10.2165/00128413-200615620-00040 Flu vaccines for paediatrics: intranasal CAIV-T vs TIV
sg:pub.10.2165/00128413-200615410-00002 Whole-virus bird flu vaccines could increase supply
sg:pub.10.2165/00128413-200715760-00004 WHO: pandemic avian flu vaccines promising, but production low
sg:pub.10.1038/482142a Lab flu may not aid vaccines
sg:pub.10.2165/00128415-201214260-00004 Novartis flu vaccines banned in Italy, Switzerland & Canada
sg:pub.10.1038/475142b Crystal ball for flu vaccines
sg:pub.10.1038/news070924-3 Do flu vaccines work for the elderly?
sg:pub.10.1038/460562a US puts flu vaccines on trial
sg:pub.10.2165/00128415-201214270-00006 Switzerland & Canada lift ban on Novartis flu vaccines
sg:pub.10.1038/495284d Flu vaccines may improve with age
sg:pub.10.1007/s10900-020-00873-1 Identifying Associations Between Influenza Vaccination Status and Access, Beliefs, and Sociodemographic Factors Among the Uninsured Population in Suffolk County, NY
sg:pub.10.1038/nrd3457 Erratum: Cell-based flu vaccines ready for US prime time
sg:pub.10.1186/cc8891 Bench-to-bedside review: Vaccine protection strategies during pandemic flu outbreaks
sg:pub.10.1038/nrd3414 Cell-based flu vaccines ready for US prime time
sg:pub.10.1038/nm.4535 A checkup for the flu vaccine
sg:pub.10.1007/bf03405265 Cost Analysis of Public Health Influenza Vaccine Clinics in Ontario
sg:pub.10.1038/nm0403-375 Looming flu pandemic has experts crying fowl
sg:pub.10.1038/nbt0213-98 Inovio
sg:pub.10.1038/nature.2013.13042 'Universal' flu vaccine effective in animals
sg:pub.10.1007/s40274-021-08017-3 A switch from syringe-and-needle to thermostable MAP flu vaccines may be cost saving in Australia
sg:pub.10.1038/s41577-019-0227-3 Antibiotics can impede flu vaccines
sg:pub.10.1038/nm1210-1347 Prospects improve for long-lasting flu vaccine
sg:pub.10.1186/s12889-022-12501-9 Vaccination against influenza among Lebanese health care workers in the era of coronavirus disease 2019
sg:pub.10.1186/s40545-022-00424-0 Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?
sg:pub.10.1038/459144a Vaccine decisions loom for new flu strain
sg:pub.10.1038/d41586-018-07034-4 The biggest pandemic risk? Viral misinformation
sg:pub.10.1038/d41586-022-03589-5 Why older people get less protection from flu vaccines
sg:pub.10.1038/d41586-019-02843-7 Neutrinos, flu vaccines and Fukushima ruling
sg:pub.10.1038/542148a Treaty to stop biopiracy threatens to delay flu vaccines
URI Description
sg:grant.8853348 Translating virus biology and host immunity for influenza control
sg:grant.3929289 Using mathematical models to optimize Ontario's emergency antiviral stockpile in time for the next flu pandemic
sg:grant.2458998 Boosting Flu Vaccination without Adjuvant Injection
sg:grant.6715148 Mucosal vaccine for influenza on inactivated virus and mannan
sg:grant.2709168 Influenza Vaccine Development
sg:grant.6729683 Understanding and Controlling Influenza
sg:grant.8794502 Universal Flu Vaccine by a Norovirus P Particle Platform
sg:grant.9422937 Novel vaccine molecules for influenza
sg:grant.8831774 Universal epitopes-based recombinant influenza vaccines
sg:grant.3829744 PLANT-BASED BIOPRODUCTION OF CHICKEN IL-12 ADJUVANT FOR BIRD FLU VACCINE
sg:grant.6542855 CAREER: An ImmunoBioEngineering Platform for Rapid and Scalable Biomanufacturing of Universal Viral Vaccines
sg:grant.8175597 Research on Vaccine Development and Cross-species Transmission Mechanism of Influenza A H1N1 Influenza
sg:grant.2666106 CD4 T cell protection in the lung
sg:grant.6729737 Development of a novel mannan-based avian influenza vaccine
sg:grant.9063883 Multi NA-based influenza vaccines
sg:grant.9553267 Vaccines that induce broadly protective antibodies against influenza virus
sg:grant.3804783 TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
sg:grant.7749449 Immunogenic Sugar Moieties as Versatile Vaccine Candidates
sg:grant.8778500 Plant-based BioProduction of Chicken IL-12 Adjuvant for Bird Flu Vaccines
sg:grant.3571453 Terahertz Spectroscopy of Mass-Manufactured Viral Vaccines
sg:grant.2459894 Development of a novel adjuvant for vaccine sparing
sg:grant.2770898 Correlation of immunogenicity with microarray analysis of vector mutants to improve live recombinant poxvirus vaccines in poultry
sg:grant.9703678 Seasonal and universal Vaccination in aged populations with pre-existing immunity
sg:grant.2355119 Chemically Programmed Immunity
sg:grant.2688107 Manipulating natural host immunoregulation via IDO during viral Infection
sg:grant.6733940 Understanding the mechanisms of action of the ISCOMATRIX adjuvant for the development of human vaccines
sg:grant.7611072 Structure-function relationships of the influenza virus RNA polymerase: influence on virulence, host restriction and innate immune responses
sg:grant.2354933 Chemically Programmed Immunity
sg:grant.7123878 The dilemma of the swine flu vaccine: A comparative study of science, decision-making and regulatory networks in three Nordic countries
sg:grant.3579092 Improving immune response to vaccines by selective targeting of epithelial regions with the Nanopatch
sg:grant.4947258 China's major seasonal flu epidemic typed memory T cell immunity age distribution of study
sg:grant.2687921 Live attenuated vaccines for epidemic and pandemic flu
sg:grant.2459401 Overcoming Immunosenescence by Nanoparticle-Mediated Activation
sg:grant.3796896 Universal Flu Vaccine
sg:grant.8347890 Synergistic Mutation of Surface Antigen of New Influenza A H1N1 Influenza Virus and Its Effect on Biological Characteristics of Virus
sg:grant.5977328 Development of influenza vaccine obtained by adding a heterologous antigen as an adjuvant
sg:grant.7908844 Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
sg:grant.7876431 Improved HIV and Influenza Vaccines
sg:grant.2458176 CD4 effector contraction in influenza
sg:grant.9291136 Deep learning models for predicting antigenic properties of influenza
sg:grant.4959371 Research dissemination and cross-species infection mechanism of influenza virus
sg:grant.7614567 Regulation of IL10 production in CD8+ T cells during Flu infection by tyrosine kinase Itk
sg:grant.7908848 Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
sg:grant.8538471 The role of LC3 Interacting Regions in Viral Subversion of Autophagy
sg:grant.7202920 Study on the Activity of Aromatic Antipyretic Chinese Medicines as Mucosal Adjuvant for Influenza Vaccine and Its Immune Mechanism in Nasal Mucosa
sg:grant.2764589 The regulation of influenza A virus replication and transcription
sg:grant.8332056 Construction of HCV vaccine with influenza virus as carrier and immune effect study
sg:grant.5503655 IMMUNITY TO CHLAMYDIA ABORTUS
sg:grant.2695836 Impact of Immunotherapy on Viral Immunity in Humans
sg:grant.6956916 Development of new concept viral vectors exerting both vaccine and adjuvant activities
URI Description
sg:pub.10.1007/978-3-030-88244-0_1 Predicting Seasonal Vaccines and H1N1 Vaccines Using Machine Learning Techniques
sg:pub.10.1007/978-1-4614-5278-2_2 Operations Research and Homeland Security: Overview and Case Study of Pandemic Influenza
sg:pub.10.1007/978-981-33-6915-3_48 Challenges Against DENV3 Vaccines: A Bioinformatic Approach
sg:pub.10.1007/978-981-16-7865-3_41 Vaccination in Pregnancy
sg:pub.10.1007/978-3-030-71165-8_31 Passive Immunization to Pandemic Viruses Through Herd Parties
sg:pub.10.1007/978-3-030-05159-4_10 European Flu Vaccine Regulations and Their Impacts in Community-Dwelling Adults
sg:pub.10.1007/978-3-0346-0279-2_14 Emulsion-Based Adjuvants for Improved Influenza Vaccines
sg:pub.10.1007/978-1-4614-0204-6_8 Influenza Pandemics
sg:pub.10.1007/978-3-319-59952-6_14 Influenza Vaccines
sg:pub.10.1007/5584_2014_31 Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project – Monitoring Vaccine Effectiveness (I-MOVE)
sg:pub.10.1007/978-3-030-05159-4_12 Direct and Indirect Benefits of a Comprehensive Approach to Vaccinating Adults with Influenza and Pneumococcal Vaccines, Especially in Patients with Chronic Diseases
sg:pub.10.1007/978-3-0346-0279-2_6 Influenza Vaccines Have a Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic
sg:pub.10.1007/978-94-011-6630-0_7 The New York Swine Influenza Immunization Program
sg:pub.10.1007/978-3-319-10951-0_87 The Roles of Mass Media and Personal Information Sources on Adoption of Pandemic Vaccines
sg:pub.10.1007/978-3-7091-0709-6_8 Cutting-Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines
sg:pub.10.1007/978-1-4020-8412-6_14 Structure, Immunopathogenesis and Vaccines Against SARS Coronavirus
sg:pub.10.1007/978-981-32-9628-2_6 Novel Vaccination Tools and Methods
sg:pub.10.1007/978-3-7643-8371-8_10 MF59: A safe and potent oil in water emulsion adjuvant for influenza vaccines, which induces enhanced protection against virus challenge
sg:pub.10.1007/978-1-4419-1132-2_15 New Strategies to Overcome the Drawbacks of Currently Available Flu Vaccines
sg:pub.10.1007/5584_2020_519 Factors Affecting Influenza Vaccination Rate in Adults with Asthma
sg:pub.10.1007/978-3-030-81170-9_1 Prediction and Control of the Impact of the Onset Influenza Season on the Spread of COVID-19
sg:pub.10.1007/978-981-15-0402-0_9 Equine Influenza Virus
sg:pub.10.1007/978-981-16-0401-0_11 Machine Learning Based Prediction of H1N1 and Seasonal Flu Vaccination
sg:pub.10.1007/978-1-59745-350-9_10 Flu-Like Syndrome and Cytokines
sg:pub.10.1007/978-94-007-6162-9_1 Introduction of Influenza A (H1N1)
sg:pub.10.1007/978-3-319-62701-4_19 MapReduce and Spark-Based Analytic Framework Using Social Media Data for Earlier Flu Outbreak Detection
sg:pub.10.1007/978-3-030-88163-4_38 Exit Strategy from COVID-19: Vaccination and Alternate Solution
sg:pub.10.1057/9781137374332_7 Pioneering Ethical Trials for Integrated Research
sg:pub.10.1007/978-1-4614-5404-5_8 Leptospira: Invasion, Pathogenesis and Persistence
sg:pub.10.1007/978-981-10-0080-5_5 Hybrid Model Based Influenza Detection with Sentiment Analysis from Social Networks
sg:pub.10.1007/978-3-030-31269-5_9 Natural Products as Possible Vaccine Adjuvants for Infectious Diseases and Cancer
sg:pub.10.1007/978-981-10-8693-9_9 Alignment-Free Analyses of Nucleic Acid Sequences Using Graphical Representation (with Special Reference to Pandemic Bird Flu and Swine Flu)
sg:pub.10.1007/978-0-306-48536-7_20 Infectious Diseases and the Development of Health Systems in Thailand
sg:pub.10.1007/978-3-030-86514-6_21 Single Model for Influenza Forecasting of Multiple Countries by Multi-task Learning
sg:pub.10.1007/978-981-10-8727-1_5 The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections
sg:pub.10.1057/9781137339218_1 Introduction: Epidemic Genre and Spanish Flu Narrative(s)
sg:pub.10.1007/978-981-15-2651-0_6 Pandemic Influenza A Virus (pH1N1)
sg:pub.10.1007/978-3-642-25731-5_13 Detecting Unexpected Correlation between a Current Topic and Products from Buzz Marketing Sites
sg:pub.10.1007/978-3-030-54161-3_395 Pandemics
sg:pub.10.1007/978-981-10-4953-8_14 Swine Flu and Pregnancy
sg:pub.10.1007/978-3-319-04211-4_6 International Control of Epidemic Diseases from a Historical and Cultural Perspective
sg:pub.10.1057/9781137339218_2 A Mundane Mystery: Framing the Flu in the First Epidemic Wave
sg:pub.10.1007/978-981-16-5755-9_15 India’s Tryst with the Second Wave of COVID-19: Politics and Policies at the Crossroads
sg:pub.10.1007/978-94-007-6162-9_3 Epidemiology of Influenza A (H1N1)
sg:pub.10.1007/978-3-030-56646-3_21 Spanish Flu: The First Modern Case of Viral Humour?
sg:pub.10.1007/978-3-642-00499-5_15 The Common Cold and the Flu
sg:pub.10.1057/9781137339218.0010 Five Visualizing the Spanish Flu Nation
sg:pub.10.1007/978-981-15-8289-9_9 Fuzzy-Based Predictive Analytics for Early Detection of Disease—A Machine Learning Approach
sg:pub.10.1007/978-3-642-38256-7_24 Online Social Networks Flu Trend Tracker: A Novel Sensory Approach to Predict Flu Trends
sg:pub.10.1007/978-1-4614-5474-8_2 Survey on the Likely Behavioural Changes of the General Public in Four European Countries During the 2009/2010 Pandemic
URI Description
sg:patent.WO-2014200325-A3 CONSORTIUM OF THE RECOMBINANT INFLUENZA A VIRUSES FLU-NS1-124- L7/L12-H5N1, FLU-NS1-124-OMP16-H5N1, FLU-NS1-124-L7/L12-H1N1 AND FLU-NS1- 124-OMP16-H1N1, FAMILY ORTOMYXOVIRIDAE, GENUS INFLUENZAVIRUS, EXPRESSING BRUCELLA IMMUNODOMINANT PROTEINS DESTINED TO GENERATE A VACCINE AGAINST BRUCELLOSIS
sg:patent.WO-2014200325-A2 CONSORTIUM OF THE RECOMBINANT INFLUENZA A VIRUSES FLU-NS1-124- L7/L12-H5N1, FLU-NS1-124-OMP16-H5N1, FLU-NS1-124-L7/L12-H1N1 AND FLU-NS1- 124-OMP16-H1N1, FAMILY ORTOMYXOVIRIDAE, GENUS INFLUENZAVIRUS, EXPRESSING BRUCELLA IMMUNODOMINANT PROTEINS DESTINED TO GENERATE A VACCINE AGAINST BRUCELLOSIS
sg:patent.US-10131695-B2 Influenza virus vaccines and uses thereof
sg:patent.US-9079944-B2 Influenza A virus vaccines and inhibitors
sg:patent.US-8916519-B2 Influenza A virus vaccines and inhibitors
sg:patent.US-8796008-B2 Influenza A virus vaccines and inhibitors
sg:patent.WO-2017137753-A1 IMPROVED FLU VACCINE YIELD
sg:patent.US-20120225068-A1 MONOCLONAL ANTIBODIES AS A MEDICAMENT FOR THE THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF SWINE-ORIGIN INFLUENZA A (H1N1) VIRUS (S-OIV) INFECTIONS
sg:patent.RU-2502745-C2 ANTI-FLU NANOANTIBODY, RECOMBINANT VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS FOR PROPHYLAXIS AND THERAPY OF A-TYPE FLU
sg:patent.WO-2020132772-A1 MONOCLONAL ANTIBODIES SPECIFIC FOR THE PB2 ANTIGEN OF THE HUMAN INFLUENZA VIRUS (FLU), NUCLEOTIDE SEQUENCES, METHOD AND DIAGNOSTIC KIT FOR FLU INFECTION
sg:patent.US-8486406-B2 Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections
sg:patent.CN-103225000-A Bird flu H7N9 virus detection reagents and detection kit
sg:patent.WO-2011074928-A1 A RECOMBINANT A/ASTANARG/6:2/2009 M-12-09/D FLU VIRUS STRAIN PRODUCED BY A REVERSE GENETICS METHOD FROM A HIGHLY PATHOGENIC DONOR STRAIN A/CHICKEN/ASTANA/6/05 (H5N1) AND A HIGHLY REPRODUCTIVE DONOR STRAIN A/PUERTO RICO/8/34 (H1N1) FROM THE ORTHOMYXOVIRIDAE FAMILY OF THE GENUS INFLUENZA VIRUS TYPE A WHICH IS DEPOSITED IN THE MICROORGANISM COLLECTION OF THE SCIENCE COMMITTEE AT THE MINISTRY OF EDUCATION AND SCIENCE OF THE REPUBLIC OF KAZAKHSTAN STATE ENTERPRISE SUBSIDIARY OF THE SCIENTIFIC RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY PROBLEMS AT THE REPUBLICAN STATE ENTERPRISE OF THE NATIONAL CENTRE FOR BIOTECHNOLOGY OF THE REPUBLIC OF KAZAKHSTAN AND CAN BE USED IN BIOTECHNOLOGY FOR THE PRODUCTION OF DIAGNOSTIC AND VACCINE PREPARATIONS AGAINST A/H5N1 FLU
sg:patent.US-8663926-B2 Detection of anthrax pathogenicity factors
sg:patent.WO-2022149619-A1 COVID 19 VIRUS/FLU AEROSOL SPRAY COMPOSITION AND METHODS FOR COMBATING, CONTRACTING AND SPREADING OF VIRUSES AND COLDS
sg:patent.WO-2008036809-A2 METHODS AND MATERIALS FOR REDUCING RISK OF COLD AND/OR FLU
sg:patent.WO-2003026567-A2 USE OF NEURAMINIDASE INHIBITORS TO PREVENT FLU ASSOCIATED BACTERIAL INFECTIONS
sg:patent.US-9365853-B2 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
sg:patent.EP-2286823-A2 Use of Cistus incanus extracts for the preparation of a medicament for the prevention and/or treatment of influenza
sg:patent.US-9752149-B2 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
sg:patent.EP-2535405-A1 A RECOMBINANT A/ASTANARG/6:2/2009 M-12-09/D FLU VIRUS STRAIN PRODUCED BY A REVERSE GENETICS METHOD FROM A HIGHLY PATHOGENIC DONOR STRAIN A/CHICKEN/ASTANA/6/05 (H5N1) AND A HIGHLY REPRODUCTIVE DONOR STRAIN A/PUERTO RICO/8/34 (H1N1) FROM THE ORTHOMYXOVIRIDAE FAMILY OF THE GENUS INFLUENZA VIRUS TYPE A WHICH IS DEPOSITED IN THE MICROORGANISM COLLECTION OF THE SCIENCE COMMITTEE AT THE MINISTRY OF EDUCATION AND SCIENCE OF THE REPUBLIC OF KAZAKHSTAN STATE ENTERPRISE SUBSIDIARY OF THE SCIENTIFIC RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY PROBLEMS AT THE REPUBLICAN STATE ENTERPRISE OF THE NATIONAL CENTRE FOR BIOTECHNOLOGY OF THE REPUBLIC OF KAZAKHSTAN AND CAN BE USED IN BIOTECHNOLOGY FOR THE PRODUCTION OF DIAGNOSTIC AND VACCINE PREPARATIONS AGAINST A/H5N1 FLU
sg:patent.US-11111277-B2 Influenza vaccines
sg:patent.US-6248721-B1 Method of using mouse model for evaluation of HIV vaccines
sg:patent.WO-1998044788-A2 ANIMAL MODEL FOR EVALUATION OF VACCINES
sg:patent.EP-4011451-A1 METAPNEUMOVIRUS MRNA VACCINES
sg:patent.EP-3992210-A1 NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES
sg:patent.WO-2017070626-A2 RESPIRATORY VIRUS VACCINES
sg:patent.WO-2022197624-A1 THERAPEUTIC USE OF SARS-COV-2 MRNA DOMAIN VACCINES
sg:patent.EP-3718565-A1 RESPIRATORY VIRUS VACCINES
sg:patent.EP-2535405-A4 A RECOMBINANT A/ASTANARG/6:2/2009 M-12-09/D FLU VIRUS STRAIN PRODUCED BY A REVERSE GENETICS METHOD FROM A HIGHLY PATHOGENIC DONOR STRAIN A/CHICKEN/ASTANA/6/05 (H5N1) AND A HIGHLY REPRODUCTIVE DONOR STRAIN A/PUERTO RICO/8/34 (H1N1) FROM THE ORTHOMYXOVIRIDAE FAMILY OF THE GENUS INFLUENZA VIRUS TYPE A WHICH IS DEPOSITED IN THE MICROORGANISM COLLECTION OF THE SCIENCE COMMITTEE AT THE MINISTRY OF EDUCATION AND SCIENCE OF THE REPUBLIC OF KAZAKHSTAN STATE ENTERPRISE SUBSIDIARY OF THE SCIENTIFIC RESEARCH INSTITUTE FOR BIOLOGICAL SAFETY PROBLEMS AT THE REPUBLICAN STATE ENTERPRISE OF THE NATIONAL CENTRE FOR BIOTECHNOLOGY OF THE REPUBLIC OF KAZAKHSTAN AND CAN BE USED IN BIOTECHNOLOGY FOR THE PRODUCTION OF DIAGNOSTIC AND VACCINE PREPARATIONS AGAINST A/H5N1 FLU
sg:patent.US-10500254-B2 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
sg:patent.AU-2013370932-B2 Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
sg:patent.EP-3118217-A1 HISTONE ANTI-CANCER VACCINES
sg:patent.EP-3446708-A1 VACCINES FOR THE TREATMENT OF CANCER AND COMPOSITIONS FOR ENHANCING VACCINE EFFICACY
sg:patent.US-9453055-B2 Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine
sg:patent.WO-2007026247-A1 VACCINES CONTAINING CORYNEBACTERIUM DIPHTHERIAE PILI
sg:patent.US-5688512-A VACCINES
sg:patent.US-9198955-B2 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
sg:patent.US-20170246295-A1 ALPHA-TOCOPHEROL-BASED ADJUVANTED SOLVENT FOR DNA VACCINES
sg:patent.WO-2021154763-A1 CORONAVIRUS RNA VACCINES
sg:patent.WO-2019036670-A3 EFFICACIOUS MRNA VACCINES
sg:patent.US-20150343040-A1 Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
sg:patent.WO-2017009349-A1 HISTONE ANTI-CANCER VACCINES
sg:patent.US-10286058-B2 Vaccines against HPV and HPV-related diseases
sg:patent.WO-2016041562-A1 ALPHA-TOCOPHEROL-BASED ADJUVANTED SOLVENT FOR DNA VACCINES
sg:patent.WO-2003051305-A3 INNATE IMMUNE SYSTEM-DIRECTED VACCINES
sg:patent.WO-2003051305-A2 INNATE IMMUNE SYSTEM-DIRECTED VACCINES
sg:patent.US-11135277-B2 Antigen specific multi epitope-based anti-infective vaccines
sg:patent.US-10350284-B1 Antigen specific multi epitope-based anti-infective vaccines
sg:patent.US-10245309-B2 Antigen specific multi epitope-based anti-infective vaccines
URI Description
sg:pub.10.1007/978-3-319-05512-1 Insight into Influenza Viruses of Animals and Humans
sg:pub.10.1007/978-1-4419-1132-2 Pharmaceutical Biotechnology
sg:pub.10.5822/978-1-61091-466-6 Seven Modern Plagues, and How We Are Causing Them
sg:pub.10.1057/9781137339218 The Spanish Flu, Narrative and Cultural Identity in Spain, 1918
sg:pub.10.1007/978-3-030-98427-4 Infection Prevention, New Perspectives and Controversies
sg:pub.10.1007/978-3-319-60980-5 Infection Prevention, New Perspectives and Controversies
sg:pub.10.1007/978-981-13-2802-2 Pandemics, Publics, and Politics, Staging Responses to Public Health Crises
sg:pub.10.1057/9780230277182 Emerging Infectious Diseases and Society
sg:pub.10.1057/9780230627611 Trust in Food, A Comparative and Institutional Analysis
sg:pub.10.1057/9780230622104 Western Spectacle of Governance and the Emergence of Humanitarian World Politics
sg:pub.10.1007/978-0-387-75722-3 Emerging Infections in Asia
sg:pub.10.1007/978-3-031-05668-0 Pandemics, Economics and Inequality, Lessons from the Spanish Flu
sg:pub.10.1007/0-387-28921-6 Crisis Management in the Food and Drinks Industry, A practical approach
sg:pub.10.1007/978-3-0346-0277-8 Replicating Vaccines, A New Generation
sg:pub.10.1007/978-0-230-23921-0 Living with Enza, The Forgotten Story of Britain and the Great Flu Pandemic of 1918
sg:pub.10.1007/978-3-319-59952-6 Pediatric Vaccines and Vaccinations, A European Textbook
sg:pub.10.1007/978-94-6091-873-5 Disaster Education, ‘Race’, Equity and Pedagogy
sg:pub.10.1007/978-94-6209-671-4 Project-Based Writing in Science
sg:pub.10.1057/9780230522619 Imagining Contagion in Early Modern Europe
sg:pub.10.1007/978-3-662-45024-6 Vaccine Analysis: Strategies, Principles, and Control
sg:pub.10.1007/978-3-7091-1818-4 Novel Technologies for Vaccine Development
sg:pub.10.1007/978-1-4939-3387-7 Vaccine Design, Methods and Protocols: Volume 1: Vaccines for Human Diseases
sg:pub.10.1007/978-1-4615-0053-7 New Bacterial Vaccines
sg:pub.10.1007/978-1-4757-9268-3 New Vaccines and Chemotherapy
sg:pub.10.1007/978-3-540-92142-4 The Algorithmic Beauty of Sea Shells
sg:pub.10.1007/978-1-4613-9226-2 Veterinary Vaccines
sg:pub.10.1007/978-3-642-23693-8 Mucosal Vaccines, Modern Concepts, Strategies, and Challenges
sg:pub.10.1007/978-3-030-77173-7 Pediatric Vaccines and Vaccinations, A European Textbook
sg:pub.10.1007/978-3-319-25832-4 Introduction to Molecular Vaccinology
sg:pub.10.1007/978-3-642-59955-2 Vaccines
sg:pub.10.1007/978-3-030-99692-5 Ethical Public Health Policy Within Pandemics, Theory and Practice in Ethical Pandemic Administration
sg:pub.10.1057/9780230282070 Catching the Flu from the United States, Synchronisation and Transmission Mechanisms to the Euro Area
sg:pub.10.1007/978-981-32-9628-2 Therapeutic Vaccines as Novel Immunotherapy, Biological and Clinical Concepts
sg:pub.10.1007/978-1-0716-1884-4 Vaccine Design, Methods and Protocols, Volume 1. Vaccines for Human Diseases
sg:pub.10.1007/978-1-0716-1888-2 Vaccine Design, Methods and Protocols, Volume 2. Vaccines for Veterinary Diseases
sg:pub.10.1007/978-1-59259-680-5 Handbook of Cancer Vaccines
sg:pub.10.1007/978-1-4939-2874-3 Carbohydrate-Based Vaccines, Methods and Protocols
sg:pub.10.1007/978-1-4899-1382-1 Novel Strategies in the Design and Production of Vaccines
sg:pub.10.1007/978-1-4615-2948-4 New Generation Vaccines, The Role of Basic Immunology
sg:pub.10.1007/978-3-319-23910-1 Cancer Vaccines
sg:pub.10.1007/978-1-4939-0345-0 Cancer Vaccines, Methods and Protocols
sg:pub.10.1007/978-1-4612-2992-6 Anti-Idiotypic Vaccines
sg:pub.10.1007/978-3-319-00978-0 Molecular Vaccines, From Prophylaxis to Therapy - Volume 2
sg:pub.10.1007/978-1-0716-1900-1 Bacterial Vaccines, Methods and Protocols
sg:pub.10.1007/978-1-4615-3848-6 Vaccines, Recent Trends and Progress
sg:pub.10.1007/978-1-4939-6869-5 Recombinant Virus Vaccines, Methods and Protocols
sg:pub.10.1007/978-3-0348-0980-1 Fish Vaccines
sg:pub.10.1007/978-3-031-10576-0 The Future of the South African Political Economy Post-COVID 19
sg:pub.10.1007/978-1-4939-3389-1 Vaccine Design, Methods and Protocols, Volume 2: Vaccines for Veterinary Diseases
sg:pub.10.1007/978-3-7091-0439-2 Gene Vaccines
URI Description
sg:clinicaltrial.NCT03180801 Phase IIb Study of the Efficacy of FLU-v, a Broad Spectrum Influenza Vaccine in an H1N1 Influenza Healthy Human Challenge Model
sg:clinicaltrial.NCT02962908 A Randomised, Double-blind, Placebo-controlled, Single-centre Phase IIb Trial as Part of the EU-funded UNISEC Project to Assess the Immunogenicity and Safety of Different Formulations and Dosing Regimens of FLU-v Vaccine in Healthy Adults
sg:clinicaltrial.NCT02765126 Clifford Craig Vaccine Trial Centre: Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Vaccine Challenge in the Elderly
sg:clinicaltrial.NCT00995527 Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine
sg:clinicaltrial.NCT03186781 VRC 316: A Phase I Open-Label Clinical Trial To Evaluate Dose, Safety, Tolerability, And Immunogenicity Of An Influenza HA Ferritin Vaccine, Alone Or In Prime-Boost Regimens With An Influenza DNA Vaccine In Healthy Adults
sg:clinicaltrial.NCT02987374 Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization
sg:clinicaltrial.NCT03814720 VRC 321: A Phase I Open-Label Clinical Trial to Evaluate Dose, Safety, Tolerability, and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine, VRCFLUNPF099-00-VP, in Healthy Adults
sg:clinicaltrial.NCT01086657 VRC 310: An Open-Label, Randomized Ph I: Healthy Adults of Prime-Boost Intervals w/Monovalent Influenza Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc), Administered Alone or Following Recombinant H5 DNA Vaccine
sg:clinicaltrial.NCT04876885 The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations
sg:clinicaltrial.NCT04565353 Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates
sg:clinicaltrial.NCT01730144 Elucidation of the Mucosal Immune Responses to Live Attenuated Influenza Vaccine In Healthy Adults
sg:clinicaltrial.NCT04590066 Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy
sg:clinicaltrial.NCT03431012 Improving Communication During a Pandemic Flu Outbreak
sg:clinicaltrial.NCT04896086 VRC 325 (000410): A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability and Immunogenicity of Mosaic Quadrivalent Influenza Vaccine With and Without Adjuplex Compared With a Licensed Inactivated Seasonal QIV, In Healthy Adults
sg:clinicaltrial.NCT04245800 Behavioral Patterns and Patient Self-completed Diagnostic Testing Study of Respiratory Viral Infection "Home Testing of Respiratory Illness"
sg:clinicaltrial.NCT00408109 VRC 304: A Phase I Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine (VRC-AVIDNA036-00-VP), Encoding for the Influenza Virus H5 Hemagglutinin Protein in Healthy Adults
sg:clinicaltrial.NCT04300868 Immunisation Status Against Major Communicable Diseases Preventable With Vaccines, and Safety of Vaccines, in a Cohort of MS Patients. An Italian Multicenter Study
sg:clinicaltrial.NCT04141917 Stepped-wedge Design Study of Point-of-care Molecular Testing for Influenza and Treatment With Baloxavir for Prevention of Secondary Transmission of Influenza in Homeless Shelters in Seattle, WA
sg:clinicaltrial.NCT00347672 Phase 1 Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca), a Live Attenuated Virus Vaccine Candidate for the Prevention of Avian Influenza H5N1 Infection in the Event of a Pandemic
sg:clinicaltrial.NCT03309618 Improving Arterial Wall Characteristics in Patients After Myocardial Infarction With a Very Low Dose of Fluvastatin and Valsartan: Proof-of-concept Study
sg:clinicaltrial.NCT03159702 Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
sg:clinicaltrial.NCT04775069 A Prospective Study Comparing the Antibody Response of Subjects With Chronic Liver Disease to mRNA, Inactivated Virus and Adenovirus Vector COVID-19 Vaccines
sg:clinicaltrial.NCT00121160 Can Stress Management Improve Vaccine Immune Response
sg:clinicaltrial.NCT05531058 [AI-driven Vaccine Communicator: The Impact of a Web-based Psychoeducation Programme With a Motivational AI-based Digital Assistant on Covid-19 Vaccine Hesitancy in Hong Kong's Population
sg:clinicaltrial.NCT04693689 Novelty, Conformity and Trust in Vaccines
sg:clinicaltrial.DRKS00027324 Vaccination and the human intestinal microbiome
sg:clinicaltrial.NCT04632537 Novel Use of an Existing Vaccine (BCG) Alliance: The NUEVA Trial
sg:clinicaltrial.NCT01377571 A Phase II, Randomized, Double-blind, Vaccine-controlled Dose-escalating Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Oral Live Attenuated Human Rotavirus (HRV) Vaccine (Rotavin-M1) in Healthy Infants in Vietnam
sg:clinicaltrial.NCT01375907 A Phase 1 Study to Evaluate Safety and Reactogenicity of a Vietnamese Rotavirus Vaccine (Rotavin-M1 at 10e6.3FFU/Dose) Among Healthy Adults in Vietnam
sg:clinicaltrial.NCT01707602 Impact of Immunization Routes on the Immune Response to Influenza Vaccine
sg:clinicaltrial.NCT04912284 Africa COVID-19 Vaccine Hesitancy: a Multi-country Cross-sectional Study
sg:clinicaltrial.NCT02710045 The Interaction Between Live and Killed Vaccines: the Effect of the Diphtheria-tetanus-whole Cell Pertussis (DTP) Combined Vaccine on T Cell Memory Following Measles Vaccination
sg:clinicaltrial.NCT00890110 Phase1/2 Study of Vaccination With DNP Modified Autologous Renal Cell Carcinoma in Combination With Sunitinib in Stage 4 RCC
sg:clinicaltrial.NCT03384316 Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
sg:clinicaltrial.NCT01187017 A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
sg:clinicaltrial.NCT00001439 A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant
sg:clinicaltrial.NCT05204602 Safety and Immunogenicity of Third Dose SARS-CoV-2 Vaccine Booster in Patients With Liver Diseases Following Two Doses of Inactivated Vaccines (NMCID-CHESS 2201): a Multicenter Cohort Study
sg:clinicaltrial.NCT02570126 Safety and Immunogenicity Study of 2 Formulations of GSK Biologicals' Varicella Vaccines Given as a 2-dose Course in the Second Year of Life.
sg:clinicaltrial.NCT00076947 Evaluation of Tolerability and Safety of a Recombinant Purified HIV Envelope Vaccine
sg:clinicaltrial.NCT04579250 VRC 323: A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults
sg:clinicaltrial.NCT02946190 A Phase II Randomized, Observer-blind Controlled Pilot Study to Compare the Safety and Immunogenicity of Acellular Pertussis Vaccines Including Chemically or Genetically-detoxified Pertussis Toxin in Adolescents Aged 11-15 Years Previously Immunized With Acellular Pertussis Vaccines
sg:clinicaltrial.NCT00051922 Evaluation of the Safety of a Polyvalent Vaccinia Virus HIV-1 Envelope Recombinant Vaccine (PolyEnv1) in Healthy Adults
sg:clinicaltrial.NCT05315583 Study of the Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies
sg:clinicaltrial.NCT05359250 Evaluation of Myocardial Dysfunction Due to mRNA-based SARS-CoV-2 Vaccines
sg:clinicaltrial.NCT05303727 Clinical Research of Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Children With Stage 4/M Neuroblastoma: A Prospective, Single-arm, Phase II, Multi-center Trial
sg:clinicaltrial.NCT01132859 VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
sg:clinicaltrial.NCT00428337 A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of DNA Vaccine EP-1233 and Recombinant MVA-HIV Polytope Vaccine MVA-mBN32, Separately and in a Combined Prime-boost Regimen, When Given to Healthy, Vaccinia-naive, HIV-1-uninfected Adults
sg:clinicaltrial.NCT04380935 Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome in Referral Hospitals in Indonesia
sg:clinicaltrial.NCT00972309 A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
sg:clinicaltrial.NCT04357535 Prognosis of SARS-Cov 2 Positive Patients Receiving Angiotensin Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Antagonists (ARBs)
URI Description
sg:ontologies/subjects/influenza-virus Influenza virus
sg:ontologies/subjects/vaccines Vaccines
sg:ontologies/subjects/inactivated-vaccines Inactivated vaccines
sg:ontologies/subjects/protein-vaccines Protein vaccines
sg:ontologies/subjects/dna-vaccines DNA vaccines
sg:ontologies/subjects/peptide-vaccines Peptide vaccines
sg:ontologies/subjects/cell-vaccines Cell vaccines
sg:ontologies/subjects/live-attenuated-vaccines Live attenuated vaccines
sg:ontologies/subjects/biomaterials-vaccines Biomaterials – vaccines
sg:ontologies/subjects/tumour-vaccines Tumour vaccines
sg:ontologies/subjects/rna-vaccines RNA vaccines
sg:ontologies/subjects/recombinant-vaccine Recombinant vaccine
sg:ontologies/subjects/conjugate-vaccines Conjugate vaccines
sg:ontologies/subjects/rotavirus Rotavirus
sg:ontologies/subjects/malaria Malaria
sg:ontologies/subjects/applied-immunology Applied immunology
sg:ontologies/subjects/cancer-immunotherapy Cancer immunotherapy
sg:ontologies/subjects/biologics Biologics
sg:ontologies/subjects/translational-immunology Translational immunology
sg:ontologies/subjects/adjuvants Adjuvants
sg:ontologies/subjects/adenovirus Adenovirus
sg:ontologies/subjects/immunotherapy Immunotherapy
sg:ontologies/subjects/public-health Public health
sg:ontologies/subjects/biolistics Biolistics
sg:ontologies/subjects/biomaterials Biomaterials
sg:ontologies/subjects/cancer-therapy Cancer therapy
sg:ontologies/subjects/microbiology Microbiology
sg:ontologies/subjects/immunology Immunology
URI Description
sg:ontologies/subjects/influenza-virus Influenza virus
sg:ontologies/subjects/vaccines Vaccines
sg:ontologies/subjects/inactivated-vaccines Inactivated vaccines
sg:ontologies/subjects/protein-vaccines Protein vaccines
sg:ontologies/subjects/dna-vaccines DNA vaccines
sg:ontologies/subjects/peptide-vaccines Peptide vaccines
sg:ontologies/subjects/cell-vaccines Cell vaccines
sg:ontologies/subjects/live-attenuated-vaccines Live attenuated vaccines
sg:ontologies/subjects/biomaterials-vaccines Biomaterials – vaccines
sg:ontologies/subjects/tumour-vaccines Tumour vaccines
sg:ontologies/subjects/rna-vaccines RNA vaccines
sg:ontologies/subjects/recombinant-vaccine Recombinant vaccine
sg:ontologies/subjects/conjugate-vaccines Conjugate vaccines
sg:ontologies/subjects/rotavirus Rotavirus
sg:ontologies/subjects/malaria Malaria
sg:ontologies/subjects/applied-immunology Applied immunology
sg:ontologies/subjects/cancer-immunotherapy Cancer immunotherapy
sg:ontologies/subjects/biologics Biologics
sg:ontologies/subjects/translational-immunology Translational immunology
sg:ontologies/subjects/adjuvants Adjuvants
sg:ontologies/subjects/adenovirus Adenovirus
sg:ontologies/subjects/immunotherapy Immunotherapy
sg:ontologies/subjects/public-health Public health
sg:ontologies/subjects/biolistics Biolistics
sg:ontologies/subjects/biomaterials Biomaterials
sg:ontologies/subjects/cancer-therapy Cancer therapy
sg:ontologies/subjects/microbiology Microbiology
sg:ontologies/subjects/immunology Immunology
URI Description
sg:journal.1284501 npj Vaccines
sg:journal.1031279 Journal of Immune Based Therapies and Vaccines
sg:journal.1363476 The Year in Hepatitis Vaccines
sg:journal.1052948 Tropical Diseases, Travel Medicine and Vaccines
sg:journal.1032339 Genetic Vaccines and Therapy
sg:journal.1021426 Current Opinion in Molecular Therapeutics
sg:journal.1050793 Current Clinical Microbiology Reports
sg:journal.1094644 Pharmaceutical Research
sg:journal.1106201 Molecular Biotechnology
sg:journal.1136149 AAPS Open
sg:journal.1020815 Pediatric Drugs
sg:journal.1383883 Molecular Genetics, Microbiology and Virology
URI Description
grid-institutes:grid.506882.1 Multi Vaccines Development Program
grid-institutes:grid.419647.9 Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences
grid-institutes:grid.420435.4 Global Vaccines (United States)
grid-institutes:grid.475702.3 Trust for Vaccines & Immunization
grid-institutes:grid.509599.9 Human Vaccines Project
grid-institutes:grid.488906.b Institute of Virology, Vaccines and Sera “Torlak”
grid-institutes:grid.475282.e International Society for Vaccines
grid-institutes:grid.497430.d Bharat Serums and Vaccines (India)
grid-institutes:grid.504806.f Meissa Vaccines (United States)
grid-institutes:grid.489072.0 National Institute for Control of Vaccines and Biologicals
grid-institutes:grid.509598.8 Human Vaccines Project Europe
grid-institutes:grid.475363.0 Global Alliance for Livestock Veterinary Medicines
URI Description
grid-institutes:grid.506882.1 Multi Vaccines Development Program
grid-institutes:grid.475702.3 Trust for Vaccines & Immunization
grid-institutes:grid.509599.9 Human Vaccines Project
grid-institutes:grid.475282.e International Society for Vaccines
grid-institutes:grid.509598.8 Human Vaccines Project Europe
grid-institutes:grid.475363.0 Global Alliance for Livestock Veterinary Medicines
URI Description
sg:person.057634154.45 H Flu
sg:person.053773054.34 P C Flu
sg:person.0607262351.06 Hans C Flu
sg:person.01164406425.50 Willem-Jan Flu
URI Description
grid-institutes:grid.420435.4 Global Vaccines (United States)
grid-institutes:grid.497430.d Bharat Serums and Vaccines (India)
grid-institutes:grid.504806.f Meissa Vaccines (United States)
URI Description
grid-institutes:grid.419647.9 Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences
grid-institutes:grid.489072.0 National Institute for Control of Vaccines and Biologicals
URI Description
grid-institutes:grid.488906.b Institute of Virology, Vaccines and Sera “Torlak”